Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/Safety of Bevacizumab Biosimilars (Zutrab vs Avastin vs Cizumab)
NCT03919448Phase 1Completed
- Sponsor
- Laboratorios Richmond
- Start
- Apr 2019
- Primary completion
- Sep 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bevacizumab in solid tumor (3 arms), sponsored by Laboratorios Richmond. Primary endpoints: Peak Serum Concentration, Area Under the Serum Concentration-time Curve (AUC0-t) and 1 more. Started Apr 2019; status: completed.
02
Drugs
bevacizumab
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03919448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919448.